Latest filing published 14 Jun 2021 for Evofem Biosciences, Inc., €4,921.
Filing timeline
BuySaleInsider track record
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
No signal scores available.
Lisa Dale Rarick: trading record in brief
Lisa Dale Rarick (board member) discloses dealings in Evofem Biosciences, Inc. to SEC (Form 4). We count 2 filings; the first trade dates from 17 June 2020 and the latest from 11 June 2021.
On the market, this insider has only ever bought: 2 purchases, €19k in total. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. In 2021 alone, the filings show 1 purchase and no sales.
Most recently, on 14 June 2021, the filings show an open-market purchase worth €4,921 in Evofem Biosciences, Inc. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Lisa Dale Rarick
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,000 shares@ US$1.198100.0% of flowCommon StockSEC:0001618835-21-000154:0Canonical exit: 9 Sept 2021 (T+90)
1 of 1 declaration